ArticleCancer chemotherapy and pharmacology2015

PLGA nanoparticle formulation of RK-33: an RNA helicase inhibitor against DDX3.

Guus Martinus Bol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.